Cognitive deterioration in adult epilepsy: Does accelerated cognitive ageing exist?

Neuroscience and Biobehavioral Reviews

Volumn 64, Issue , 2016, Pages 1-11

  Breuer, L E M ^a,b   Boon, P ^a,c   Bergmans, J W M ^b   Mess, W H ^d   Besseling, R M H ^b   de Louw, A ^a,b   Tijhuis, A G ^b   Zinger, S ^b   Bernas, A ^b   Klooster, D C W ^b   Aldenkamp, A P ^a,b,c,d  

^a EPILEPSY CENTER KEMPENHAEGHE   (Netherlands)

^b EINDHOVEN UNIVERSITY OF TECHNOLOGY   (Netherlands)

^c GHENT UNIVERSITY HOSPITAL   (Belgium)

^d MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Accelerated cognitive ageing; Cognition; Cognitive ageing; Cognitive decline; Cognitive deterioration; Cognitive trajectory; Epilepsy; Risk factors

Indexed keywords

ANTICONVULSIVE AGENT; PHENOBARBITAL; PHENYTOIN; TOPIRAMATE;

AGING; ALZHEIMER DISEASE; BRAIN DISEASE; CEREBROVASCULAR ACCIDENT; COMORBIDITY; CONNECTOME; DISEASE COURSE; DISEASE DURATION; EPILEPSY; EPILEPTIC STATE; HIGH RISK POPULATION; HUMAN; LATE ONSET DISORDER; MENTAL DETERIORATION; MILD COGNITIVE IMPAIRMENT; NERVE CELL NETWORK; NERVE CELL PLASTICITY; NONHUMAN; ONSET AGE; PRIORITY JOURNAL; RASMUSSEN SYNDROME; REVIEW; RISK ASSESSMENT; RISK FACTOR; TEMPORAL LOBE EPILEPSY; TONIC CLONIC SEIZURE; TRAUMATIC BRAIN INJURY; TREATMENT RESPONSE; VASCULAR DISEASE; BRAIN; COGNITIVE AGING; DRUG EFFECTS; PATHOPHYSIOLOGY; PHYSIOLOGY; PSYCHOLOGY;

BRAIN; COGNITIVE AGING; EPILEPSY; HUMANS;

EID: 84959090142     PISSN: 01497634     EISSN: 18737528     Source Type: Journal    
DOI: 10.1016/j.neubiorev.2016.02.004     Document Type: Review

References (132)

1. Acharya J.N., Acharya V.J. Epilepsy in the elderly: special considerations and challenges. Ann. Indian Acad. Neurol. 2014, 17:18-26.
2. Adachi N., Kanemoto K., Muramatsu R., Kato M., Akanuma N., Ito M., Onuma T. Intellectual prognosis of status epilepticus in adult epilepsy patients: analysis with wechsler adult intelligence scale-revised. Epilepsia 2005, 46:1502-1509.
3. Aikia M., Kalviainen R., Sivenius J., Halonen T., Riekkinen P.J. Cognitive effects of oxcarbazapine and phenytoin monotherapy in newly diagnosed epilepsy: one year follow-up. Epilepsy Res. 1992, 11:199-203.
4. Aikia M., Kalviainen R., Riekkinen P. Five-year follow-up of cognitive performance of adult patients with well-controlled partial epilepsy. Epilepsia 1999, 40:100-101.
5. Aikia M., Salmenpera T., Partanen K., Kalviainen R. Verbal memory in newly diagnosed patients and patients with chronic left temporal lobe epilepsy. Epilepsy Behav. 2001, 2:20-27.
6. Aldenkamp A.P. Antiepileptic drugs and cognitive disorders. The Neuropsychiatry of Epilepsy 2011, 153-163. Cambridge University Press, Cambridge. M.R.B. Trimble Schmitz (Ed.).
7. Aldenkamp A.P., Alpherts W.C., Diepman L., Slot van 't B., Overweg J., Vermeulen J. Cognitive side-effects of phenytoin compared with carbamazepine in patients with localization-related epilepsy. Epilepsy Res. 1994, 19:37-43.
8. Amatniek J.C., Hauser W.A., DelCastillo-Castaneda C., Jacobs D.M., Marder K., Bell K., Stern Y. Incidence and predictors of seizures in patients with Alzheimer's disease. Epilepsia 2006, 47:867-872.
9. Andersson-Roswall L., Engman E., Samuelsson H., Sjöberg-Larsson C., Malmgren K. Verbal memory decline and adverse effects on cognition in adult patients with pharmacoresistant partial epilepsy: a longitudinal controlled study of 36 patients. Epilepsy Behav. 2004, 5:677-686.
10. Andrews P.I., Dichter M.A., Berkovic S.F., Newton M.R., McNamara J.O. Plasmapheresis in Rasmussen's encephalitis. Neurology 1996, 46:242-246.
11. Annegers J.F., Hauser W.A., Coan S.P., Rocca W.A. A population-based study of seizures after traumatic brain injuries. New Engl. J. Med. 1998, 338:20-24.
12. Baker G.A., Taylor J., Aldenkamp A.P. Newly diagnosed epilepsy: cognitive outcome after 12 months. Epilepsia 2011, 52:1084-1091.
13. Baram T.Z. The brain, seizures and epilepsy throughout life: understanding a moving target. Epilepsy Curr. 2012, 12:7-12.
14. Baxendale S., Heaney D., Thompson P.J., Duncan J.S. Cognitive consequences of childhood-onset temporal lobe epilepsy across the adult lifespan. Neurology 2010, 75:705-711.
15. Berg A.T., Berkovic S.F., Brodie M.J., Buchhalter J., Cross J.H., van Emde Boas W., Scheffer I.E. Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on Classification and Terminology 2005-2009. Epilepsia 2010, 51:676-685.
16. Berg A.T., Zelko F.A., Levy S.R., Testa F.M. Age at onset of epilepsy; pharmacoresistance, and cognitive outcomes. A prospective cohort study. Neurology 2012, 79:1384-1391.
17. Bernhardt B.C., Worsley K.J., Kim H., Evans A.C., Bernasconi A., Bernasconi N. Longitudinal and cross-sectional analysis of atrophy in pharmacoresistant temporal lobe epilepsy. Neurology 2009, 72:1747-1754.
18. Bettcher B.M., Kramer J.H. Longitudinal inflammation, cognitive decline, and Alzheimer's disease: a mini-review. Clin. Pharmacol. Therap. 2014, 96:464-469.
19. Bien C.G., Granata T., Antozzi C., Cross J.H., Dulac O., Kurthen M., Elger C.E. Pathogenesis, diagnosis and treatment of Rasmussen encephalitis. A European consensus statement. Brain 2005, 128:454-471.
20. Black L.C., Schefft B.K., Howe S.R., Szaflarski J.P., Yeh H.-S., Privitera M.D. The effect of seizures on working memory and executive functioning performance. Epilepsy Behav. 2010, 17:412-419.
21. Bonilha L., Tabesh A., Dabbs K., Hsu D.A., Stafstrom C.E., Hermann B.P., Lin J.J. Neurodevelopmental alterations of large-scale structural networks in children with new-onset epilepsy. Hum. Brain Mapp. 2014, 35:3661-3672.
22. Bourgeois B.F.D., Prensky A.L., Palkes H.S., Talent B.K., Busch S.G. Intelligence in epilepsy: a prospective study in children. Ann. Neurol. 1983, 14:438-444.
23. Braakman H.M., Vaessen M.J., Hofman P.A., Debeij-van Hall M.H., Backes W.H., Vles J.S., Aldenkamp A.P. Cognitive and behavioral complications of frontal lobe epilepsy in children: a review of the literature. Epilepsia 2011, 52:849-856.
24. Brodie M.J., Elder A.T., Kwan P. Epilepsy in later life. Lancet Neurol. 2009, 8:1019-1030.
25. Calandre E.P., Dominguez-Granados R., Gomez-Rubio M., Molina-Font J.A. Cognitive effects of long-term treatment with phenobarbital and valproic acid in school children. Acta Neurol. Scand. 1990, 81:504-506.
26. Chin J., Scharfman H.E. Shared cognitive and behavioral impairments in epilepsy and Alzheimer's disease and potential underlying mechanisms. Epilepsy Behav. 2013, 26:343-351.
27. Cleary P., Shorvon S., Tallis R. Late-onset seizures as a predictor of subsequent stroke. Lancet 2004, 363:1184-1186.
28. Coan A.C., Appenzeller S., Bonilha L., Li L.M., Cendes F. Seizure frequency and lateralization affect progression of atrophy in temporal lobe epilepsy. Neurology 2009, 73:834-842.
29. Comijs H.C., Kriegsman D.M.W., Dik M.G., Deeg D.J.H., Jonker C., Stalman W.A.B. Somatic chronic diseases and 6-year change in cognitive functioning among older persons. Arch. Gerontol. Geriatr. 2009, 48:191-196.
30. Cordonnier C., Hénon H., Derambure P., Dasquier F., Leys D. Early epileptic seizures after stroke are associated with increased risk of new-onset dementia. J. Neurol. Neurosurg. Psychiatry 2007, 78:514-516.
31. Cumbo E., Ligori L.D. Levetiracetam, lamotrigine, and phenobarbital in patients with epileptic seizures and Alzheimer's disease. Epilepsy Behav. 2010, 17:461-466.
32. Dabbs K., Becker T., Jones J., Rutecki P., Seidenberg M., Hermann B. Brain structure and aging in chronic temporal lobe epilepsy. Epilepsia 2012, 53:1033-1043.
33. De Reuck J., De Clerck M., Van Maele G. Vascular cognitive impairment in patients with late-onset seizures after an ischemic stroke. Clin. Neurol. Neurosurg. 2006, 108:637-643.
34. De Reuck J., Claeys I., Martens S., Vanwalleghem Ph., Maele G., van Phlypo R., Hallez H. Computed tomographic changes of the brain and clinical outcome of patients with seizures and epilepsy after an ischaemic hemispheric stroke. Eur. J. Neurol. 2006, 13:402-407.
35. Debette S., Seshadri S., Beiser A., Au R., Himali J.J., Palumbo C., Wolf P.A., DeCarli C. Midlife vascular risk factor exposure accelerates structural brain aging and cognitive decline. Neurology 2011, 77:461-468.
36. Dietl T., Urbach H., Helmstaedter C., Staedtgen M., Szentkuti A., Grunwald T., Kurthen M. Persistent severe amnesia due to seizure recurrence after unilateral temporal lobectomy. Epilepsy Behav. 2004, 5:394-400.
37. Dik M.G., Jonker C., Hack C.E., Smit J.H., Comijs H.C., Eikelenboom P. Serum inflammatory proteins and cognitive decline in older persons. Neurology 2005, 64:1371-1377.
38. Dodrill C.B. Correlates of generalized tonic-clonic seizures with intellectual, neuropsychological, emotional, and social function in patients with epilepsy. Epilepsia 1986, 27:399-411.
39. Dodrill C.B. Neuropsychological effects of seizures. Epilepsy Behav. 2004, 5:21-24.
40. Dodrill C.B., Wilensky A.J. Intellectual impairment as an outcome of status epilepticus. Neurology 1990, 40:23-27.
41. Dodrill C.B., Wilensky A.J. Neuropsychological abilities before and after 5 years of stable antiepileptic drug therapy. Epilepsia 1992, 33:327-334.
42. Doucet G.E., Sharan A., Pustina D., Skidmore C., Sperling M.R., Tracy J.I. Early and late age of seizure onset have a differential impact on brain resting-state organization in temporal lobe epilepsy. Brain Topogr. 2014, 10.1007/s10548-014-0366-6.
43. Dubeau F., Andermann F., Wiendl H., Bar-Or A. Rasmussen's encephalitis (chronic focal encephalitis). Epilepsy. A Comprehensive Textbook 2008, 2439-2453. Lippincott Williams & Wilkins, Philadelphia; USA. J. Engel, T.A. Pedley (Eds.).
44. Dulac O. Epileptic encephalopathy. Epilepsia 2001, 42:23-26.
45. Elger C.E., Helmstaedter C., Kurthen M. Chronic epilepsy and cognition. Lancet Neurol. 2004, 3:663-672.
46. Elliott J.O., Jacobson M.P., Haneef Z. Cardiovascular risk factors and homocysteine in epilepsy. Epilepsy Res. 2007, 76:113-123.
47. Engelberts N.H.J., Klein M., Ploeg van der H.M., Heimans J.J., Ader H.J., Boxtel van M.P.J., Kasteleijn-Nolst Trenité D.G.A. Cognition and health-related quality of life in a well-defined subgroup of patients with partial epilepsy. J. Neurol. 2002, 249:294-299.
48. Filippini M., Arzimanoglou A., Gobbi G. Neuropsychological approaches to epileptic encephalopathies. Epilepsia 2013, 54:38-44.
49. Fisher R.S., Emde Boas van W., Blume W., Elger C., Genton P., Lee P., Engel J. Epileptic seizures and epilepsy: definitions proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE). Epilepsia 2005, 46:470-472.
50. Förstl H., Burns A., Levy R., Cairns N., Luthert P., Lantos P. Neurologic signs in Alzheimer's disease: results of a prospective clinical and neuropathologic study. Arch. Neurol. 1992, 49:1038-1042.
51. Friedman D., Honig L.S., Scarmeas N. Seizures and epilepsy in Alzheimer's disease. CNS Neurosci. Therap. 2012, 18:285-294.
52. Fritz N., Glogau S., Hoffmann J., Rademacher M., Elger C.E., Helmstaedter C. Efficacy and cognitive side effects of tiagabine and topiramate in patients with epilepsy. Epilepsy Behav. 2005, 6:373-381.
53. Fujikawa D.G., Licht E.A., Jacobsen R.H. Chronic epileptic encephalopathy in adult patients with bilaterally synchronous frequent and/or prolonged subclinical epileptiform discharges. Epilepsy Behav. 2012, 25:442-448.
54. Gaitatzis A., Carroll K., Majeed A., Sander J.W. The epidemiology of the comorbidity of epilepsy in the general population. Epilepsia 2004, 45:1613-1622.
55. Gaitatzis A., Sisodiya S.M., Sander, JW The somatic comorbidity of epilepsy: a weighty but often unrecognized burden. Epilepsia 2012, 53:1282-1293.
56. Gillham R.A., Williams N., Wiedmann K.D., Butler E., Larkin J.G., Brodie M.J. Cognitive function in adult epileptic patients established on anticonvulsant monotherapy. Epilepsy Res. 1990, 7:219-225.
57. Gorelick P.B., Scuteri A., Black S.E., DeCarli C., Greenberg S.M., Iadecola C., Seshadri S. Vascular contributions to cognitive impairment and dementia. a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2011, 42:2672-2713.
58. Griffith H.R., Martin R.C., Bambara J.K., Faught E., Vogtle L.K., Marson D.C. Cognitive functioning over 3 years in community dwelling older adults with chronic partial epilepsy. Epilepsy Res. 2007, 74:91-96.
59. Gupta Y.K., Gupta M. Post-traumatic epilepsy: a review of scientific evidence. Indian J. Physiol. Pharmacol. 2006, 50:7-16.
60. Haltiner A.M., Temkin N.R., Winn H.R., Dikmen S.S. The impact of posttraumatic seizures on 1-year neuropsychological and psychosocial outcome of head injury. J. Int. Neuropsychol. Soc. 1996, 2:494-504.
61. Hamed S.A., Hamed E.A., Hamdy R., Nabeshima T. Vascular risk factors and oxidative stress as independent predictors of asymptomatic atherosclerosis in adult patients with epilepsy. Epilepsy Res. 2007, 74:183-192.
62. Helmstaedter C. Cognitive outcome of status epilepticus in adults. Epilepsia 2007, 48:85-90.
63. Helmstaedter C., Elger C.E. Chronic temporal lobe epilepsy: a neurodevelopmental or progressively dementing disease?. Brain 2009, 132:2822-2830.
64. Helmstaedter C., Kurthen M., Lux S., Reuber M., Elger C.E. Chronic epilepsy and cognition: a longitudinal study in temporal lobe epilepsy. Ann. Neurol. 2003, 54:425-432.
65. Hendriks M.P., Aldenkamp A.P., Alpherts W.C., Ellis J., Vermeulen J., van der H., Vlugt Relationships between epilepsy-related factors and memory impairment. Acta Neurologica Scandinavica 2004, 110:291-300.
66. Hermann B., Seidenberg M., Schoenfeld J., Davies K. Neuropsychological characteristics of the syndrome of mesial temporal lobe epilepsy. Arch. Neurol. 1997, 54:369-376.
67. Hermann B., Jones J., Sheth R., Dow C., Koehn M., Seidenberg M. Children with new-onset epilepsy: neuropsychological status and brain structure. Brain 2006, 129:2609-2619.
68. Hermann B., Seidenberg M., Dow C., Jones J., Rutecki P., Bhattacharya A., Bell B. Cognitive prognosis in chronic temporal lobe epilepsy. Ann. Neurol. 2006, 60:80-87.
69. Hermann B., Seidenberg M., Lee E.J., Chan F., Rutecki P. Cognitive phenotypes in temporal lobe epilepsy. J. Int. Neuropsychol. Soc. 2007, 13:12-20.
70. Hermann B., Seidenberg M., Sager M., Carlsson C., Gidal B., Sheth R., Rutecki P., Asthana S. Growing old with epilepsy: the neglected issue of cognitive and brain health in aging and elder persons with chronic epilepsy. Epilepsia 2008, 49:731-740.
71. Holmes M.D., Dodrill C.B., Wilkus R.J., Ojemann L.M., Ojemann G.A. Is partial epilepsy progressive? Ten-year follow-up of EEG and neuropsychological changes in adults with partial seizures. Epilepsia 1998, 39:1189-1193.
72. Hommet C., Mondon K., Camus V., De Toffol B., Constans T. Epilepsy and dementia in the elderly. Dement. Geriatr. Cogn. Disord. 2008, 25:293-300.
73. Irizarry M.C., Jin S., He F., Emond J.A., Raman R., Thomas R.G., Aisen P.S. Incidence of new-onset seizures in mild to moderate Alzheimer disease. Arch. Neurol. 2012, 69:368-372.
74. Jefferson A.L., Massaro J.M., Wolf P.A., Seshadri S., Au R., Vasan R.S., DeCarli C. Inflammatory biomarkers are associated with total brain volume. The Framingham Heart Study. Neurology 2007, 68:1032-1038.
75. Jokeit H., Ebner A. Long term effects of refractory temporal lobe epilepsy on cognitive abilities: a cross sectional study. J. Neurol. Neurosurg. Psychiatry 1999, 67:44-50.
76. Kaaden S., Helmstaedter C. Age at onset of epilepsy as a determinant of intellectual impairment in temporal lobe epilepsy. Epilepsy Behav. 2009, 15:213-217.
77. Kolakowsky-Hayner S.A., Wright J., Englander J., Duong T., Ladley-O'Brien S. Impact of late post-traumatic seizures on physical health and functioning for individuals with brain injury within the community. Brain Inj. 2013, 27:578-586.
78. Korman B., Krsek P., Duchowny M., Maton B., Pacheco-Jacome E., Rey G. Early seizure onset and dysplastic lesion extent independently disrupt cognitive networks. Neurology 2013, 81:745-751.
79. Krumholz A., Sung G.Y., Fisher R.S., Barry E., Bergey G.K., Grattan L.M. Complex partial status epilepticus accompanied by serious morbidity and mortality. Neurology 1995, 45:1499-1504.
80. Kumral E., Uncu G., Dönmez I., Cerrahoglu Şirin T., Alpaydin S., Çalli C., Kitiş Ö. Impact of poststroke seizures on neurological deficits: magnetic resonance diffusion-weighted imaging study. Eur. Neurol. 2013, 69:200-206.
81. Kwan P., Brodie M.J. Neuropsychological effects of epilepsy and antiepileptic drugs. Lancet 2001, 357:216-222.
82. Lee S., Sziklas V., Andermann F., Farnham S., Risse G., Gustafson M., Jones-Gotman M. The effects of adjunctive topiramate on cognitive function in patients with epilepsy. Epilepsia 2003, 44:339-347.
83. Lee H.-W., Jung D.-K., Suh C.-K., Kwon S.-H., Park S.-P. Cognitive effects of low-dose topiramate monotherapy in epilepsy patients: a 1-year follow-up. Epilepsy Behav. 2006, 8:736-741.
84. Leppik I.E., Birnbaum A.K. Epilepsy in the elderly. Ann. N. Y. Acad. Sci. 2010, 1184:208-224.
85. Li X., Breteler M.M.B., Bruyne de M.C., Meinardi H., Hauser W.A., Hofman A. Vascular determinants of epilepsy: The Rotterdam Study. Epilepsia 1997, 38:1216-1220.
86. Lin J.J., Mula M., Hermann B.P. Uncovering the neurobehavioural comorbidities of epilepsy over the lifespan. Lancet 2012, 380:1180-1192.
87. Loiseau P., Strube E., Broustet D., Battellochi S., Gomeni C., Morselli P.L. Learning impairment in epileptic patients. Epilepsia 1983, 24:183-192.
88. LoPinto-Khoury C., Mintzer S. Antiepileptic drugs and markers of vascular risk. Curr. Treat. Opt. Neurol. 2010, 12:300-308.
89. Manni R., Ratti M.T., Perucca E., Calimberti C.A., Tartara A. A multiparametric investigation of daytime sleepiness and psychomotor functions in epileptic patients treated with phenobarbital and sodium valproate: a comparative controlled study. Electroencephalogr. Clin. Neurophysiol. 1993, 86:322-328.
90. Marques C.M., Caboclo L.O.S.F., da Silva T.I., da Silva Noffs M.H., Carrete H., Lin K., Yacubian E.M.T. Cognitive decline in temporal lobe epilepsy due to unilateral hippocampal sclerosis. Epilepsy Behav. 2007, 10:477-485.
91. Meador K.J., Loring D.W., Hulihan J.F., Kamin M., Karim R. Differential cognitive and behavioral effects of topiramate and valproate. Neurology 2003, 60:1483-1488.
92. Moretti L., Cristofori I., Weaver S.M., Chau A., Portelli J.N., Grafman J. Cognitive decline in older adults with a history of traumatic brain injury. Lancet Neurol. 2012, 11:1103-1112.
93. Olesen J.B., Abildstrøm S.Z., Erdal J., Gislason G.H., Weeke P., Andersson C., Torp-Pedersen C., Hansen P.R. Effects of epilepsy and selected antiepileptic drugs on risk of myocardial infarction, stroke, and death in patients with or without previous stroke: a nationwide cohort study. Pharmacoepidemiol. Drug Safety 2011, 20:964-971.
94. Ortinski P., Meador K.J. Cognitive side effects of antiepileptic drugs. Epilepsy Behav. 2004, 5:60-65.
95. Overvliet G.M., Besseling R.M., Vles J.S., Hofman P.A., Backes W.H., Hall van M.H., Aldenkamp A.P. Nocturnal epileptiform EEG discharges; nocturnal epileptic seizures; and language impairments in children: review of the literature. Epilepsy Behav. 2010, 19:550-558.
96. Oyegbile T.O., Dow C., Jones J., Bell B., Rutecki P., Sheth R., Hermann B.P. The nature and course of neuropsychological morbidity in chronic temporal lobe epilepsy. Neurology 2004, 62:1736-1742.
97. Palop J.J., Mucke L. Epilepsy and cognitive impairments in Alzheimer disease. Arch. Neurol. 2009, 66:435-440.
98. 43.007). Neurology 2014, 82(10 Suppl). S43-007.
99. Piazzini A., Canevini M.P., Turner K., Chifari R., Canger R. Elderly people and epilepsy: cognitive function. Epilepsia 2006, 47:82.
100. Pitkänen A., Sutula T.P. Is epilepsy a progressive disorder? Prospects for new therapeutic approaches in temporal-lobe epilepsy. Lancet Neurol. 2002, 1:173-181.
101. Pulliainen V., Jokelainen M. Comparing the cognitive effects of phenytoin and carbamazepine in long-term monotherapy: a two-year follow-up. Epilepsia 1995, 36:1192-1202.
102. Pulliainen V., Kuikka P., Jokelainen M. Motor and cognitive functions in newly diagnosed adult seizure patients before antiepileptic medication. Acta Neurol. Scand. 2000, 101:73-78.
103. Rafnsson S.B., Deary I.J., Smith F.B., Whiteman M.C., Fowkes F.G.R. Cardiovascular diseases and decline in cognitive function in an elderly community population: The Edinburgh Artery Study. Psychosom. Med. 2007, 69:425-434.
104. Raymont V., Salazar A.M., Lipsky R., Goldman D., Tasick G., Grafman J. Correlates of posttraumatic epilepsy 35 years following combat brain injury. Neurology 2010, 75:224-229.
105. Roberson E.D., Hope O.A., Martin R.C., Schmidt D. Geriatric epilepsy: research and clinical directions for the future. Epilepsy Behav. 2011, 22:103-111.
106. Rosano C., Marsland A.L., Gianaros P.J. Maintaining brain health by monitoring inflammatory processes: a mechanism to promote successful aging. Aging Dis. 2012, 3:16-33.
107. Seidenberg M., Pulsipher D.T., Hermann B. Cognitive progression in epilepsy. Neuropsychol. Rev. 2007, 17:445-454.
108. Shlosberg D., Benifla M., Kaufer D., Friedman A. Blood-brain barrier breakdown as a therapeutic agent in traumatic brain injury. Nat. Rev. Neurol. 2010, 6:393-403.
109. Smith C. Review: the long-term consequences of microglial activation following acute traumatic brain injury. Neuropathol. Appl. Neurobiol. 2013, 39:35-44.
110. Stefan H., May T.W., Pfäfflin M., Brandt C., Füratsch N., Schmitz B., Kerling F. Epilepsy in the elderly: comparing clinical characteristics with younger patients. Acta Neurol. Scand. 2014, 129:283-293.
111. Sulzbacher S., Farwell J.R., Temkin N., Lu A.S., Hirtz D.G. Late cognitive effects of early treatment with phenobarbital. Clin. Pediatr. 1999, 38:387-394.
112. Szaflarski J.P., Nazzal Y., Dreer L.E. Post-traumatic epilepsy: current and emerging treatment options. Neuropsychiatr. Dis. Treat. 2014, 10:1469-1477.
113. Taylor J., Baker G.A. Newly diagnosed epilepsy: cognitive outcome at 5 years. Epilepsy Behav. 2010, 18:397-403.
114. Taylor J., Kolamunnage-Dona R., Marson A.G., Smith P.E.M., Aldenkamp A.P., Baker G.A. Patients with epilepsy: cognitively compromised before the start of antiepileptic drug treatment?. Epilepsia 2010, 51:48-56.
115. Tedrus G.M.A.S., Fonseca L.C., Junior E.N., Pazetto D. Epilepsy with onset at over 50 years of age: clinical and electroencephalographic characteristics. Arquivos de Neuropsiquiatra 2012, 70:780-785.
116. Thom M., Liu J.Y., Thompson P., Phadke R., Narkiewicz M., Martinian L., Sisodiya S.M. Neurofibrillary tangle pathology and Braak staging in chronic epilepsy in relation to traumatic brain injury and hippocampal sclerosis: a post-mortem study. Brain 2011, 10.1093/brain/awr209.
117. Thompson P.J., Duncan J.S. Cognitive decline in severe intractable epilepsy. Epilepsia 2005, 46:1780-1787.
118. Thompson P.J., Baxendale S.A., Duncan J.S., Sander J.W.A.S. Effects of topiramate on cognitive function. J. Neurol. Neurosurg. Psychiatry 2000, 69:636-641.
119. Tomkins O., Feintuch A., Benifla M., Cohen A., Friedman A., Shelef I. Blood-brain barrier breakdown following traumatic brain injury: a possible role in posttraumatic epilepsy. Cardiovasc. Psychiatry Neurol. 2011, 10.1155/2011/765923.
120. Tosun D., Dabbs K., Caplan R., Siddarth P., Toga A., Seidenberg M., Hermann B. Deformation-based morphometry of prospective neurodevelopmental changes in new onset paediatric epilepsy. Brain 2011, 134:1003-1014.
121. Trinka E. Epilepsy: comorbidity in the elderly. Acta Neurol. Scand. 2003, 108:33-36.
122. Vaessen M.J., Jansen J.F., Vlooswijk M.C., Hofman P.A., Majoie H.J., Aldenkamp A.P., Backes W.H. White matter abnormalities are associated with cognitive decline in chronic epilepsy. Cereb. Cortex 2011, 10.1093/cercor/bhr298.
123. Van Bogaert P. Epileptic encephalopathy with continuous spike-waves during slow-wave sleep including Landua-Kleffner syndrome. Handbook Clin. Neurol. 2012, 111:634-640.
124. Verellen R.M., Cavazos J.E. Pathophysiological considerations of seizures, epilepsy, and status epilepticus in the elderly. Aging Dis. 2011, 2:278-285.
125. Vermeulen J., Aldenkamp A.P. Cognitive side-effects of chronic antiepileptic drug treatment: a review of 25 years of research. Epilepsy Res. 1995, 22:65-95.
126. Villani F., Pincherle A., Antozzi C., Chiapparini L., Granata T., Michelucci R., Spreafico R. Adult-onset Rasmussen's encephalitis: anatomical-electrographic-clinical features of 7 Italian Cases. Epilepsia 2006, 47:41-46.
127. Vining E.P.G., Mellits E.D., Dorsen M.M., Cataldo M.F., Quaskey S.A., Spielberg S.P., Freeman J.M. Psychologic and behavioral effects of antiepileptic drugs in children: a double-blind comparison between phenobarbital and valproic acid. Pediatrics 1987, 80:165-174.
128. Vlooswijk M.C.G., Vaessen M.J., Jansen J.F.A., Krom de M.C.F.T.M., Majoie H.J.M., Hofman P.A.M., Backes W.H. Loss of network efficiency associated with cognitive decline in chronic epilepsy. Neurology 2011, 77:938-944.
129. Vossel K.A., Beagle A.J., Rabinovici G.D., Shu H., Lee S.E., Naasan G., Mucke L. Seizures and epileptiform activity in the early stages of Alzheimer disease. JAMA Neurol. 2013, 70:1158-1166.
130. Wang W.-H., Liou H.-H., Chen C.-C., Chiu M.-J., Chen T.-F., Cheng T.-W., Hua M.-S. Neuropsychological performance and seizure-related risk factors in patients with temporal lobe epilepsy: a retrospective cross-sectional study. Epilepsy Behav. 2011, 22:728-734.
131. Witt J.A., Helmstaedter C. Should cognition be screened in new-onset epilepsies? A study in 247 untreated patients. J. Neurol. 2012, 259:1727-1731.
132. Woodward K.E., Gaxiola-Valdez I., Goodyear B.G., Federico P. Frontal lobe epilepsy alters functional connections within the brain's motor network: a Resting-State fMRI Study. Brain Connect. 2014, 4:91-99.